Last reviewed · How we verify
NCT05110625: preDIABETEXT
mHealth Intervention to Prevent Type 2 Diabetes Mellitus (Phase II Study)
NA trial testing preDIABE-TEXT in Prediabetic State in 365 participants. Completed in 31 May 2023.
31 May 2023
Quick facts
| Lead sponsor | Fundació d'investigació Sanitària de les Illes Balears |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 365 |
| Start date | 1 December 2021 |
| Primary completion | 31 May 2023 |
| Estimated completion | 31 May 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- preDIABE-TEXT
- Online Education
Conditions studied
- Prediabetic State — all drugs for Prediabetic State →
Sponsor
Fundació d'investigació Sanitària de les Illes Balears
Who can join
Adults 18 to 75, any sex, with Prediabetic State. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to develop and evaluate a low intensity, multifaceted, digital health intervention to prevent T2DM based on: i) the use of a system comprising mobile health (mHealth) technology integrated with electronic health records to send tailored text messages (SMSs) promoting lifestyle changes in people at risk of T2DM, and, ii) the provision of online education to primary healthcare workers about prediabetes management.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Development and Evaluation of a Digital Health Intervention to Prevent Type 2 Diabetes in Primary Care: The PREDIABETEXT Study Protocol for a Randomised Clinical Trial.
Galmes-Panades AM, Angullo E, Mira-Martínez S, Bennasar-Veny M, et al · · 2022 · cited 3× · PMID 36429423 · DOI 10.3390/ijerph192214706 -
Describing the initial results of a pragmatic, cluster randomized clinical trial to examine the impact of a multifaceted digital intervention for the prevention of type 2 diabetes mellitus in the primary care setting: intervention design, recruitment strategy and participants' ba
Mira-Martínez S, Zamanillo-Campos R, Malih N, Fiol-deRoque MA, et al · · 2025 · cited 2× · PMID 40230484 · DOI 10.3389/fendo.2025.1524336 -
A Multifaceted Digital Intervention for the Prevention of Type 2 Diabetes Mellitus in Primary Care (PREDIABETEXT): Cluster Randomized Trial.
Mira-Martínez S, Malih N, Angullo-Martínez E, Zamanillo-Campos R, et al · · 2025 · PMID 41067715 · DOI 10.2196/70981
Verify or expand the search:
- PubMed search for NCT05110625
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prediabetic State
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT06897982 — Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center · NA · recruiting
- NCT06118931 — Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control · NA · recruiting
- NCT06471569 — Role of Aging and Individual Variation in Exercise Training Responsiveness · NA · recruiting
- NCT06723886 — Antidiabetic Effect of Olive Pomace Oil · NA · recruiting
Other Fundació d'investigació Sanitària de les Illes Balears trials
Trials by the same sponsor.
- NCT07528937 — APPLICATION OF 3D RECONSTRUCTION FOR PREOPERATIVE STRATEGY OF LOCALLY ADVANCED COLON CANCER · NA · not yet recruiting
- NCT07011368 — Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project · NA · not yet recruiting
- NCT06576466 — Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke · NA · recruiting
- NCT06582498 — Short Questionnaire to Assess Individual Needs in Cancer Survivors in a Clinical Setting · NA · completed
- NCT05907785 — Biomarkers of Physical Activity/health in Children and Adolescents · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05110625 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundació d'investigació Sanitària de les Illes Balears
- Last refreshed: 23 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05110625.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing